Cash Flows from Operating Activities | |
Net income | |
Adjustments to reconcile net income to net cash provided by operating activities: | |
Depreciation and amortization | |
Provision for doubtful accounts | |
Non-cash stock-based compensation | 6.76M |
Excess tax benefits from stock-based payment arrangements | |
Disposal of property and equipment | |
Amortization of deferred financing costs | |
Write-off of deferred financing costs | |
Deferred income taxes | |
Amortization of discount and accretion on debt | |
Changes in operating assets and liabilities: | |
Accounts receivable | -136.38M |
Payments on notes receivable | |
Other current and non-current assets | |
Accounts payable and accrued liabilities | 40.95M |
Employee compensation and benefits | |
Insurance liability risks | |
Other long-term liabilities | |
Net cash provided by operating activities | 35.3M |
Cash Flows from Investing Activities | |
Additions to property and equipment | -70.79M |
Acquistion of healthcare facilities and businesses | |
Acquisition of home health licenses | |
Proceeds from sale of property and equipment | |
Net cash used in investing activities | 962K |
Cash Flows from Financing Activities | |
Borrowings under line of credit | 662M |
Repayments under line of credit | -611M |
Repayments of long-term debt and capital leases | |
Proceeds from issuance long-term debt | 354.14M |
Additions to deferred financing costs | |
Exercise of stock options | |
Excess tax benefits from stock-based payment arrangements | |
Taxes paid related to net share settlement of equity awards | |
Net cash (used in) provided by financing activities | -43.97M |
Increase (decrease) in cash and cash equivalents | -7.7M |
Cash and cash equivalents at beginning of period | 61.54M |
Cash and cash equivalents at end of period | 53.84M |